MedPath

Effectiveness of Drotaverine HCL in reducing the duration of first stage of labour among nulliparous women at Federal Teaching Hospital, Abakaliki.

Phase 1
Conditions
Pregnancy and Childbirth
Registration Number
PACTR201810902005232
Lead Sponsor
Ikeotuonye Arinze
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
Female
Target Recruitment
220
Inclusion Criteria

Nullipara or primigravida
Cervical dilation of 4-5cm only
Consent
No prior use of spasmolytics

Exclusion Criteria

Term PROM
Coexisting masses
Allergy to Drotaverine HCL
Multipara
Postdatism

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of first stage of labour
Secondary Outcome Measures
NameTimeMethod
Pain, mode of delivery, maternal sideeffects, APGAR score at 1st and 5th minute, need for augmentation of abour
© Copyright 2025. All Rights Reserved by MedPath